Zai Lab (ZLAB) Long-Term Investments (2016 - 2024)
Zai Lab's (ZLAB) quarterly Long-Term Investments came in at $3.1 million in Q4 2024, down 66.21% year-on-year from $9.2 million in Q1 2024, and down 1.21% quarter-over-quarter from $3.2 million in Q3 2024.
Zai Lab (ZLAB) Long-Term Investments (2016 - 2024) Analysis & Trends
Zai Lab has disclosed Long-Term Investments across 9 years of filings, most recently posting $3.1 million for Q4 2024.
- Long-Term Investments for Q4 2024 came in at $3.1 million, down 66.21% year-over-year; the trailing twelve-month figure through Dec 2024 was $3.1 million (down 66.21% YoY), and the FY2024 annual result was $3.1 million, down 66.21% from the prior year.
- Long-Term Investments came in at $3.1 million for Q4 2024 at Zai Lab, down from $3.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $20.8 million in Q3 2021 to a low of $1.1 million in Q2 2021.
- The 5-year median for Long-Term Investments is $4.5 million (2023), against an average of $6.6 million.
- Across the five-year window, Long-Term Investments soared 1120.09% in 2021 and sank 84.06% in 2022, its largest moves.
- Zai Lab's Long-Term Investments stood at $1.3 million in 2020, then jumped by 1120.09% to $15.6 million in 2021, then plunged by 58.79% to $6.4 million in 2022, then surged by 43.37% to $9.2 million in 2023, then plunged by 66.21% to $3.1 million in 2024.
- The last three Long-Term Investments figures came in at $3.1 million (Q4 2024), $3.2 million (Q3 2024), and $4.1 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 14.11 Mn |
| Dec 31, 2023 | 9.22 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 6.43 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 8.44 Mn |
| Dec 31, 2021 | 15.61 Mn |
| Sep 30, 2021 | 20.80 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 1.28 Mn |
| Dec 31, 2019 | 2.40 Mn |
| Dec 31, 2018 | 3.15 Mn |
| Dec 31, 2017 | 1.65 Mn |